Allarity Therapeutics, Inc. (ALLR) › Shareholders' EquityAllarity Therapeutics, Inc. (ALLR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $20.04M2020: $24.44M2021: $18.15M2022: -$113.0K2023: -$2.75M2024: $11.81M2025: $9.83M$9.83M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$9.83M-16.8%2024$11.81M+529.3%2023-$2.75M-2334.5%2022-$113.0K-100.6%2021$18.15M-25.7%2020$24.44M+22.0%2019$20.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share